GNIPST Bulletin 41.2

8/10/2019 GNIPST Bulletin 41.2

1/19

09-01-2015G

G

N

N

I

I

P

P

S

S

T

T

U

U

L

L

L

L

T

T

I

I

N

N

2

2

1

1

5

5

09th

January, 2015 Volume No.: 41 Issue No.: 02

Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE

OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE BAS

LEARNING AND PRACTICE

ontentsMessage from PRINCIPAL

Editorial board

Historical article

News Update

Knowledge based Article

Disease Related Breaking

News

Upcoming Events

Drugs Update

Campus News

Students Section

Editors Note

Archive

GNIPST Photo Gallery

or your comments/contribution

For ack-Issues,

ailto:[email protected]

GURU NANAK INSTITUTE OF PHARMACEUTICAL

SCIENCE AND TECHNOLOGY

Website:http://gnipst.ac.in
https://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7mailto:[email protected]:[email protected]:[email protected]://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7


2/19

09-01-2015

MESSAGE FROM PRINCIPAL

"It can happen. It does happen.

But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do.

Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank tlast years editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academexcellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners asupported in maximizing their potential and talents. Education needs to focus on personalized learni

and instruction, while promoting an education system that is impartial, universally accessible, and meeti

the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order achieve their aims. We are all very proud of you, our students, and your accomplishments and loo

forward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looki

forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken

this direction and fruits of these efforts will be received by our students in the near future. Our Teache

are committed and dedicated for the development of the institution by imparting their knowledge and pl

the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positi

challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holist

needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of t

opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us

this path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1


3/19


4/19

09-01-2015

Ritual circumcision linked to increased risk of

autism in young boys: (09thJanuary, 2015)Circumcised boys are more likely than intact boys to develop

autism spectrum disorder before the age of 10, new researchsuggests. Painful experiences in neonates have been shown inanimal and human studies to be associated with long-termalterations in pain perception, a characteristic often encounteredamong children with ASD.

Cancer biopsies do not promote cancer spread,

research finds: (09thJanuary, 2015)A study of more than 2,000 patients has dispelled the myth that

cancer biopsies cause cancer to spread. The researchers show thatpatients who received a biopsy had a better outcome and longersurvival than patients who did not have a biopsy.

Bacteria could contribute to development of

wound-induced skin cancer: (09thJanuary, 2015)A new mechanism by which skin damage triggers the formation oftumors has been discovered by researchers, which could have

important therapeutic implications for patients suffering withchronic ulcers or skin blistering diseases.

Tumor-blocking role found for cell regulation

molecule: (09thJanuary, 2015)The role of a protein in regulating tumor development has beenstudied by researchers who have found that it suppresses livercancer growth in the lab. The investigation has focused on the roleof a protein controlled by JNK and p38, known as ATF2, in tumor

development.


3


5/19

09-01-2015

Study supports link between injectable hormonal

contraceptive and HIV risk: (09th January,

2015)Women using depot medroxyprogesterone acetate, commonlyknown as Depo-Provera or the birth control shot, have amoderately increased risk of becoming infected with HIV, a largemeta-analysis of 12 studies involving more than 39,500 women hasfound. Other forms of hormonal contraception, including oralcontraceptive pills, do not appear to increase this risk.

Common human protein linked to adverse

parasitic worm infections: (08

th

January, 2015)Worm infections represent a major global public health problem,leading to a variety of debilitating diseases and conditions.Scientists have made a discovery that could lead to more effectivediagnostic and treatment strategies for worm infections and theirsymptoms. The researchers found that resistin, an immune proteincommonly found in human serum, instigates an inappropriateinflammatory response to worm infections, impairing the clearanceof the worm.

Scientists explain spread of chikungunya vector:

(08thJanuary, 2015)The tropical disease chikungunya began twisting Western tonguesin July when the first locally transmitted case was reported inFlorida. Spotted in the Caribbean just last year, the disease spreadexplosively throughout the Americas in 2014. Chikungunya'sarrival in Panama prompted Smithsonian scientists to examinehow human activity spreads its mosquito vector and the seriousimplications this has for disease ecology everywhere.


4


6/19

09-01-2015

Neuroprosthetics for paralysis: Biocompatible,

flexible implant slips into the spinal cord: (08th

January, 2015)New therapies are on the horizon for individuals paralyzedfollowing spinal cord injury. The e-Dura implant can be applieddirectly to the spinal cord without causing damage andinflammation, scientists report.

Exposure to nanoparticles may threaten heart

health: (08thJanuary, 2015)While nanotechnology has led to countless advancements, a group

of researchers is now raising a flag of caution about its effects onour health. They say exposure to tiny silica-based particles canplay a big role in increasing heart attack and stroke risks.

For detail mail toeditor

KNOWLEDGE BASED ARTICLE

MRSA

Methicillin-resistantStaphylococcus aureus(MRSA) isabacterium responsible for several difficult-to-treatinfections inhumans. It is also called oxacillin-resistantStaphylococcusaureus(ORSA). MRSA is any strain ofStaphylococcus aureusthat hasdeveloped, through the process ofnaturalselection,resistancetobeta-lactam antibiotics, which includethepenicillins (methicillin,dicloxacillin,nafcillin,oxacillin, etc.)and thecephalosporins. Strains unable to resist these antibioticsare classified as methicillin-sensitive Staphylococcus aureus, orMSSA.Theevolutionof such resistance does not cause the organism to bemore intrinsicallyvirulent than strains of S. aureusthat have noantibiotic resistance, but resistance does make MRSA infectionmore difficult to treat with standard types of antibiotics and thusmore dangerous.


5
mailto:[email protected]:[email protected]://en.wikipedia.org/wiki/Bacteriumhttp://en.wikipedia.org/wiki/Infectionhttp://en.wikipedia.org/wiki/Staphylococcus_aureushttp://en.wikipedia.org/wiki/Staphylococcus_aureushttp://en.wikipedia.org/wiki/Staphylococcus_aureushttp://en.wikipedia.org/wiki/Natural_selectionhttp://en.wikipedia.org/wiki/Natural_selectionhttp://en.wikipedia.org/wiki/Antibiotic_resistancehttp://en.wikipedia.org/wiki/Beta-lactam_antibioticshttp://en.wikipedia.org/wiki/Penicillinhttp://en.wikipedia.org/wiki/Methicillinhttp://en.wikipedia.org/wiki/Dicloxacillinhttp://en.wikipedia.org/wiki/Nafcillinhttp://en.wikipedia.org/wiki/Oxacillinhttp://en.wikipedia.org/wiki/Cephalosporinhttp://en.wikipedia.org/wiki/MSSAhttp://en.wikipedia.org/wiki/Evolutionhttp://en.wikipedia.org/wiki/Virulence_factorhttp://en.wikipedia.org/wiki/Virulence_factorhttp://en.wikipedia.org/wiki/Evolutionhttp://en.wikipedia.org/wiki/MSSAhttp://en.wikipedia.org/wiki/Cephalosporinhttp://en.wikipedia.org/wiki/Oxacillinhttp://en.wikipedia.org/wiki/Nafcillinhttp://en.wikipedia.org/wiki/Dicloxacillinhttp://en.wikipedia.org/wiki/Methicillinhttp://en.wikipedia.org/wiki/Penicillinhttp://en.wikipedia.org/wiki/Beta-lactam_antibioticshttp://en.wikipedia.org/wiki/Antibiotic_resistancehttp://en.wikipedia.org/wiki/Natural_selectionhttp://en.wikipedia.org/wiki/Natural_selectionhttp://en.wikipedia.org/wiki/Staphylococcus_aureushttp://en.wikipedia.org/wiki/Infectionhttp://en.wikipedia.org/wiki/Bacteriummailto:[email protected]


7/19

09-01-2015

MRSA is especially troublesome in hospitals, prisons, and nursinghomes, where patients with open wounds, invasive devices, andweakenedimmune systemsare at greater risk ofnosocomialinfection than the general public. MRSA began as ahospital-

acquired infection,but has developed limited endemic status andis now sometimes community-acquired. The terms HA-MRSA(healthcare-associated MRSA) and CA-MRSA(community-associated MRSA) reflect this distinction.Signs and Symptoms:S. aureusmost commonly colonizes theanteriornares (thenostrils). The rest of therespiratory tract, openwounds,intravenouscatheters, and theurinary tractare also

potential sites for infection. Healthy individuals may carry MRSAasymptomatically for periods ranging from a few weeks to manyyears. Patients withcompromisedimmune systemsare at asignificantly greater risk of symptomaticsecondary infection.In most patients, MRSA can be detected by swabbing the nostrilsand isolating the bacteria found inside the nostrils. Combined withextra sanitary measures for those in contact with infected patients,swab screening patients admitted to hospitals has been found tobe effective in minimizing the spread of MRSA in hospitals.MRSA may progress substantially within 2448 hours of initialtopical symptoms. After 72 hours, MRSA can take hold in humantissues and eventually become resistant to treatment. The initialpresentation of MRSA is small red bumps that resemble pimples,spider bites, or boils; they may be accompanied by fever and,occasionally, rashes. Within a few days, the bumps become largerand more painful; they eventually open into deep, pus-filledboils. About 75 percent of community-associated (CA-) MRSA

infections are localized to skin and soft tissue and usually can betreated effectively. Some CA-MRSA strains displayenhancedvirulence, spreading more rapidly and causing illnessmuch more severe than traditional HA-MRSA infections, and theycan affect vital organs and lead to widespread infection(sepsis),toxic shock syndrome, andnecrotizing("flesh-


6
http://en.wikipedia.org/wiki/Immune_systemhttp://en.wikipedia.org/wiki/Nosocomial_infectionhttp://en.wikipedia.org/wiki/Nosocomial_infectionhttp://en.wikipedia.org/wiki/Hospital-acquired_infectionhttp://en.wikipedia.org/wiki/Hospital-acquired_infectionhttp://en.wikipedia.org/wiki/Anterior_nareshttp://en.wikipedia.org/wiki/Anterior_nareshttp://en.wikipedia.org/wiki/Nostrilshttp://en.wikipedia.org/wiki/Respiratory_tracthttp://en.wikipedia.org/wiki/Intravenoushttp://en.wikipedia.org/wiki/Catheterhttp://en.wikipedia.org/wiki/Urinary_tracthttp://en.wikipedia.org/wiki/Immunodeficiencyhttp://en.wikipedia.org/wiki/Immune_systemhttp://en.wikipedia.org/wiki/Secondary_infectionhttp://en.wikipedia.org/wiki/Virulencehttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Toxic_shock_syndromehttp://en.wikipedia.org/wiki/Necrotizinghttp://en.wikipedia.org/wiki/Necrotizinghttp://en.wikipedia.org/wiki/Toxic_shock_syndromehttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Virulencehttp://en.wikipedia.org/wiki/Secondary_infectionhttp://en.wikipedia.org/wiki/Immune_systemhttp://en.wikipedia.org/wiki/Immunodeficiencyhttp://en.wikipedia.org/wiki/Urinary_tracthttp://en.wikipedia.org/wiki/Catheterhttp://en.wikipedia.org/wiki/Intravenoushttp://en.wikipedia.org/wiki/Respiratory_tracthttp://en.wikipedia.org/wiki/Nostrilshttp://en.wikipedia.org/wiki/Anterior_nareshttp://en.wikipedia.org/wiki/Anterior_nareshttp://en.wikipedia.org/wiki/Hospital-acquired_infectionhttp://en.wikipedia.org/wiki/Hospital-acquired_infectionhttp://en.wikipedia.org/wiki/Nosocomial_infectionhttp://en.wikipedia.org/wiki/Nosocomial_infectionhttp://en.wikipedia.org/wiki/Immune_system


8/19

09-01-2015

eating")pneumonia.This is thought to be due to toxins carried byCA-MRSA strains, such asPVLandPSM,though PVL was recentlyfound not to be a factor in a study by theNational Institute ofAllergy and Infectious Diseases at the National Institutes of

Health. It is not known why some healthy people develop CA-MRSA skin infections that are treatable while others infected withthe same strain develop severe infections or die.People are very commonly colonized with CA-MRSA and arecompletely asymptomatic. The most common manifestations ofCA-MRSA are simple skin infections, suchasimpetigo,boils,abscesses,folliculitis, andcellulitis. Rarer, butmore serious, manifestations can occur, such asnecrotizing

fasciitisandpyomyositis(most commonly found in thetropics),necrotizing pneumonia,infective endocarditis(whichaffects the valves of the heart), and bone and joint infections. CA-MRSA often results in abscess formation that requires incision anddrainage. Before the spread of MRSA into the community,abscesses were not considered contagious, because infection wasassumed to require violation of skin integrity and the introductionof staphylococci from normal skin colonization. However, newlyemerging CA-MRSA is transmissible (similar, but with very

important differences) from HA-MRSA. CA-MRSA is less likelythan other forms of MRSA to cause cellulitis.Diagnosis:Diagnostic microbiology laboratories and reference laboratories arekey for identifying outbreaks of MRSA. Faster techniques foridentifying and characterizing MRSA have recently beendeveloped. Normally, the bacterium must be cultured from blood,urine,sputum, or other body-fluid samples, and in sufficient

quantities to perform confirmatory tests early-on. Still, because noquick and easy method exists to diagnose MRSA, initial treatmentof the infection is often based upon 'strong suspicion' andtechniques by the treating physician; these includequantitativePCR procedures, which are employed in clinical laboratories forquickly detecting and identifying MRSA strains.


7
http://en.wikipedia.org/wiki/Pneumoniahttp://en.wikipedia.org/wiki/Panton-Valentine_leukocidinhttp://en.wikipedia.org/wiki/Phenol-soluble_modulinhttp://en.wikipedia.org/wiki/National_Institute_of_Allergy_and_Infectious_Diseaseshttp://en.wikipedia.org/wiki/National_Institute_of_Allergy_and_Infectious_Diseaseshttp://en.wikipedia.org/wiki/Impetigohttp://en.wikipedia.org/wiki/Boilshttp://en.wikipedia.org/wiki/Abscesseshttp://en.wikipedia.org/wiki/Folliculitishttp://en.wikipedia.org/wiki/Cellulitishttp://en.wikipedia.org/wiki/Necrotizing_fasciitishttp://en.wikipedia.org/wiki/Necrotizing_fasciitishttp://en.wikipedia.org/wiki/Pyomyositishttp://en.wikipedia.org/wiki/Necrotizing_pneumoniahttp://en.wikipedia.org/wiki/Infective_endocarditishttp://en.wikipedia.org/wiki/Sputumhttp://en.wikipedia.org/wiki/Quantitative_PCRhttp://en.wikipedia.org/wiki/Quantitative_PCRhttp://en.wikipedia.org/wiki/Quantitative_PCRhttp://en.wikipedia.org/wiki/Quantitative_PCRhttp://en.wikipedia.org/wiki/Sputumhttp://en.wikipedia.org/wiki/Infective_endocarditishttp://en.wikipedia.org/wiki/Necrotizing_pneumoniahttp://en.wikipedia.org/wiki/Pyomyositishttp://en.wikipedia.org/wiki/Necrotizing_fasciitishttp://en.wikipedia.org/wiki/Necrotizing_fasciitishttp://en.wikipedia.org/wiki/Cellulitishttp://en.wikipedia.org/wiki/Folliculitishttp://en.wikipedia.org/wiki/Abscesseshttp://en.wikipedia.org/wiki/Boilshttp://en.wikipedia.org/wiki/Impetigohttp://en.wikipedia.org/wiki/National_Institute_of_Allergy_and_Infectious_Diseaseshttp://en.wikipedia.org/wiki/National_Institute_of_Allergy_and_Infectious_Diseaseshttp://en.wikipedia.org/wiki/Phenol-soluble_modulinhttp://en.wikipedia.org/wiki/Panton-Valentine_leukocidinhttp://en.wikipedia.org/wiki/Pneumonia


9/19

09-01-2015

Another common laboratory test is a rapidlatex agglutinationtestthat detects the PBP2a protein. PBP2a is a variantpenicillin-binding protein that imparts the ability of S. aureusto be resistant tooxacillin.

Treatment:Both CA-MRSA and HA-MRSA are resistant to traditional anti-staphylococcalbeta-lactam antibiotics, such ascephalexin. CA-MRSA has a greater spectrum of antimicrobial susceptibility,including tosulfa drugs (likeco-trimoxazole/trimethoprim-sulfamethoxazole),tetracyclines (likedoxycyclineandminocycline)andclindamycin (forosteomyelitis), but the drug of choice fortreating CA-MRSA is now believed to bevancomycin,according to

a Henry Ford Hospital Study. HA-MRSA is resistant even to theseantibiotics and often is susceptible only to vancomycin. Newerdrugs, such aslinezolid(belonging to theneweroxazolidinones class) anddaptomycin, are effective againstboth CA-MRSA and HA-MRSA. The Infectious Disease Society ofAmerica recommends vancomycin, linezolid, or clindamycin (ifsusceptible) for treating patients with MRSApneumonia. Ceftaroline, a fifth generation cephalosporin, is thefirst beta-lactam antibiotic approved in the US to treat MRSAinfections (skin and soft tissue or community acquired pneumoniaonly).Vancomycin andteicoplanin areglycopeptide antibioticsused totreat MRSA infections. Teicoplaninis a structuralcongener ofvancomycin that has a similar activity spectrum but a longerhalf-life. Because the oral absorption of vancomycin andteicoplaninisvery low, these agents must be administered intravenously tocontrol systemic infections. Treatment of MRSA infection with

vancomycin can be complicated, due to its inconvenient route ofadministration. Moreover, many clinicians believe that the efficacyof vancomycin against MRSA is inferior to that of anti-staphylococcalbeta-lactam antibioticsagainst methicillin-susceptible Staphylococcus aureus(MSSA).


8
http://en.wikipedia.org/wiki/Agglutination_(biology)http://en.wikipedia.org/wiki/Penicillin-binding_proteinhttp://en.wikipedia.org/wiki/Penicillin-binding_proteinhttp://en.wikipedia.org/wiki/Beta-lactam_antibiotichttp://en.wikipedia.org/wiki/Cephalexinhttp://en.wikipedia.org/wiki/Sulfonamide_(medicine)http://en.wikipedia.org/wiki/Co-trimoxazolehttp://en.wikipedia.org/wiki/Tetracycline_antibioticshttp://en.wikipedia.org/wiki/Doxycyclinehttp://en.wikipedia.org/wiki/Minocyclinehttp://en.wikipedia.org/wiki/Clindamycinhttp://en.wikipedia.org/wiki/Osteomyelitishttp://en.wikipedia.org/wiki/Vancomycinhttp://en.wikipedia.org/wiki/Linezolidhttp://en.wikipedia.org/wiki/Oxazolidinoneshttp://en.wikipedia.org/wiki/Daptomycinhttp://en.wikipedia.org/wiki/Ceftarolinehttp://en.wikipedia.org/wiki/Teicoplaninhttp://en.wikipedia.org/wiki/Glycopeptide_antibioticshttp://en.wikipedia.org/wiki/Teicoplaninhttp://en.wikipedia.org/wiki/Congener_(chemistry)http://en.wikipedia.org/wiki/Exponential_decay%23Natural_scienceshttp://en.wikipedia.org/wiki/Exponential_decay%23Natural_scienceshttp://en.wikipedia.org/wiki/Teicoplaninhttp://en.wikipedia.org/wiki/Beta-lactam_antibiotichttp://en.wikipedia.org/wiki/Beta-lactam_antibiotichttp://en.wikipedia.org/wiki/Teicoplaninhttp://en.wikipedia.org/wiki/Exponential_decay%23Natural_scienceshttp://en.wikipedia.org/wiki/Exponential_decay%23Natural_scienceshttp://en.wikipedia.org/wiki/Congener_(chemistry)http://en.wikipedia.org/wiki/Teicoplaninhttp://en.wikipedia.org/wiki/Glycopeptide_antibioticshttp://en.wikipedia.org/wiki/Teicoplaninhttp://en.wikipedia.org/wiki/Ceftarolinehttp://en.wikipedia.org/wiki/Daptomycinhttp://en.wikipedia.org/wiki/Oxazolidinoneshttp://en.wikipedia.org/wiki/Linezolidhttp://en.wikipedia.org/wiki/Vancomycinhttp://en.wikipedia.org/wiki/Osteomyelitishttp://en.wikipedia.org/wiki/Clindamycinhttp://en.wikipedia.org/wiki/Minocyclinehttp://en.wikipedia.org/wiki/Doxycyclinehttp://en.wikipedia.org/wiki/Tetracycline_antibioticshttp://en.wikipedia.org/wiki/Co-trimoxazolehttp://en.wikipedia.org/wiki/Sulfonamide_(medicine)http://en.wikipedia.org/wiki/Cephalexinhttp://en.wikipedia.org/wiki/Beta-lactam_antibiotichttp://en.wikipedia.org/wiki/Penicillin-binding_proteinhttp://en.wikipedia.org/wiki/Penicillin-binding_proteinhttp://en.wikipedia.org/wiki/Agglutination_(biology)


10/19

09-01-2015

Several newly discovered strains of MRSA showantibioticresistanceeven to vancomycin andteicoplanin. These newevolutions of the MRSA bacterium have been dubbedVancomycinintermediate-resistantStaphylococcus

aureus(VISA). Linezolid,quinupristin/dalfopristin,daptomycin,ceftaroline, andtigecyclineare used to treat more severe infectionsthat do not respond to glycopeptides such as vancomycin. Currentguidelines recommenddaptomycin for VISA bloodstreaminfections and endocarditis.

Jeenatara BegumAssistant Professor

GNIPST

DISEASE RELATED BREAKING NEWS

Middle East respiratory syndrome coronavirus

(MERS-CoV) Jordan: (5thJanuary, 2015)On 25 December 2014, the National IHR Focal Point of Jordannotified WHO of 1 additional case of Middle East respiratorysyndrome coronavirus (MERS-CoV) infection.Read more

UPCOMING EVENTS

The 66th Indian Pharmaceutical Congress will be organised atHitex Exhibition Centre, Hyderabad on 23rdto 25thJanuary, 2015.

On 28th January to 31st January, 2015 the Chemtech & Pharma

World Expo 2015 will be held at Bombay Exhibition Centre,Goregaon (E), Mumbai, India.


9
http://en.wikipedia.org/wiki/Antibiotic_resistancehttp://en.wikipedia.org/wiki/Antibiotic_resistancehttp://en.wikipedia.org/wiki/Teicoplaninhttp://en.wikipedia.org/wiki/Vancomycin-resistant_Staphylococcus_aureushttp://en.wikipedia.org/wiki/Vancomycin-resistant_Staphylococcus_aureushttp://en.wikipedia.org/wiki/Vancomycin-resistant_Staphylococcus_aureushttp://en.wikipedia.org/wiki/Vancomycin-resistant_Staphylococcus_aureushttp://en.wikipedia.org/wiki/Vancomycin-resistant_Staphylococcus_aureushttp://en.wikipedia.org/wiki/Linezolidhttp://en.wikipedia.org/wiki/Quinupristin/dalfopristinhttp://en.wikipedia.org/wiki/Daptomycinhttp://en.wikipedia.org/wiki/Ceftarolinehttp://en.wikipedia.org/wiki/Ceftarolinehttp://en.wikipedia.org/wiki/Tigecyclinehttp://en.wikipedia.org/wiki/Daptomycinhttp://www.who.int/csr/don/05-january-2015-mers-jordan/en/http://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docxhttp://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docxhttp://www.who.int/csr/don/05-january-2015-mers-jordan/en/http://en.wikipedia.org/wiki/Daptomycinhttp://en.wikipedia.org/wiki/Tigecyclinehttp://en.wikipedia.org/wiki/Ceftarolinehttp://en.wikipedia.org/wiki/Ceftarolinehttp://en.wikipedia.org/wiki/Daptomycinhttp://en.wikipedia.org/wiki/Quinupristin/dalfopristinhttp://en.wikipedia.org/wiki/Linezolidhttp://en.wikipedia.org/wiki/Vancomycin-resistant_Staphylococcus_aureushttp://en.wikipedia.org/wiki/Vancomycin-resistant_Staphylococcus_aureushttp://en.wikipedia.org/wiki/Vancomycin-resistant_Staphylococcus_aureushttp://en.wikipedia.org/wiki/Teicoplaninhttp://en.wikipedia.org/wiki/Antibiotic_resistancehttp://en.wikipedia.org/wiki/Antibiotic_resistance


11/19

09-01-2015

DRUGS UPDATES

FDA Approves Savaysa (edoxaban) to Prevent

Embolic Events in Non-Valvular Atrial

Fibrillation: (8thJanuary, 2015)The U.S. Food and Drug Administration approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk ofstroke and dangerous blood clots (systemic embolism) in patientswith atrial fibrillation that is not caused by a heart valve problem.Read more

CAMPUS NEWS

On 22ndDecember 2014 the students of B.Pharm 2ndyear and B.Sc2nd year visited the laboratory of Vivekananda Institute of

Biotechnology, Sri Ramkrishna Ashram, Nimpith under the

supervision of Mr. Samrat Bose, Ms Jeentara Begum, Mr. Soumya

Bhattacharya and Ms. Aparupa Bhattacharya.

Some of the teachers of GNIPST attended the 4th InternationalConference of World Science Congress at Jadavpur University on 16th

December to 18thDecember 2014.

Congratulation to Tamalika Chakraborty, Assistant Professor ofGNIPST, who got 3rd prize for the poster presentation in the

National Seminar on Opportunity in Medicinal Plant Research,

Jadavpur University, Kolkata, India from 29th -30th November,

2014.

On 29th November and 30th November many of the faculty

members and students of GNIPST presented their posters in theNational Seminar on Opportunity in Medicinal Plant Research,

Jadavpur University, Kolkata, India from 29th -30th November,

2014.

The teachers and students of GNIPST attended the National


10
http://www.drugs.com/newdrugs/fda-approves-savaysa-edoxaban-prevent-embolic-events-non-valvular-atrial-fibrillation-4146.htmlhttp://www.drugs.com/newdrugs/fda-approves-savaysa-edoxaban-prevent-embolic-events-non-valvular-atrial-fibrillation-4146.htmlhttp://www.drugs.com/newdrugs/fda-approves-savaysa-edoxaban-prevent-embolic-events-non-valvular-atrial-fibrillation-4146.html


12/19

09-01-2015

workshop on Redefining the Role of Pharmacist in Health Care

System which was held in Dr. H. L. Roy Auditorium, Jadavpur

Universirty Kolkata-700032 on 16th November 2014, organised by

Indian Pharmaceutical Association, Bengal Branch, Kolkata

Congratulation to Rupam Saha, student of M.Pharm 2ndyear, whogot 1stprize for the poster presentation in the National seminar on

Control of Viral Menace using Delivery Design organised by Dr.

B.C.Roy College of Pharmacy & AHS in association with IPA

Bengal Branch.

On 14thand 15thNovember 2014 the Industrial visit of B.Pharm 2ndyear students was conducted in East India Pharmaceutical Works

Limited, Kolkata under the supervision of Mr. Jaydip Roy, Mr.

Debabrata Ghoshdastidar, Mr. Samrat Bose, Ms Jeentara Begum,

Mr. Soumya Bhattacharya and Ms. Moumita Chowdhury.

A Debate on Unity was held on 14thNovember 2014 and the jointwinner was Sreejit Roy , Bsc 2nd year and Pratik Nandi ,Bsc firstyear (Chairperson of debate: Dr Lopamudra Datta and Ms.Priyanka Ray).

On 14th

November, 2014 a Quiz competition was held on WorldDiabetes Day and the winner was Pratik Nandi and Sreyosi Dey,

Bsc first year.

Runner up Anirban Roy and Ankur Mondal B.Pharm third year

(Quiz Master: Mr. Soumya Bhattacharya)

A Seminar was held on 14th November 2014 World Diabetes Dayon Angiogenesis and Role of Amino Acids by Dr Debatosh Datta,

Research scientist.GNIPST commemorated the 126th Birth Anniversary of Maulana

Abul Kalam Azad on Tuesday, 11th November 2014.

On 7thNovember 2014 the students of GNIPST participated in theRun for Unity as a mark of tribute to the efforts of the country'sfirst Home Minister Sardar Vallabhbhai Patel.


11
http://economictimes.indiatimes.com/topic/Sardar%20Vallabhbhai%20Patelhttp://economictimes.indiatimes.com/topic/Sardar%20Vallabhbhai%20Patel


13/19

09-01-2015

Congratulation to the winner of Cricket Tournament-B.Pharm 3rdyear, 2014Runner up team-B.Sc and BHM, 2014

Congratulation to the highest run scorer of Cricket Tournament-Tanmoy Das Biswas, B.Pharm 3rd year, 2014

Congratulation to the highest wicket taker of CricketTournament-Subhodip Das, B.Pharm 3rd year, 2014

Congratulation to the winner of Carom Tournament (Boys)-Sk. Abdul Salam, B.Pharm 2ndyear, 20141st Runner up-Subhayan Dutta, M.Sc (Biotechnology Department)

2nd year, 2014

2nd Runner up-Nirupan Gupta, B.Pharm 1

st

year, 2014Congratulation to the winner of Carom Tournament (Girls)-

Aishwarya Datta, B.Pharm 2ndyear, 20141st Runner up-Krishnakali Basu, B.Pharm 3rdyear, 2014

2nd Runner up-Rituparna Das, B.Pharm 3rdyear, 2014

Congratulation to the winner of Chess Tournament (Boys)-Basab Brata Dey, M.Sc (Biotechnology Department) 2ndyear, 20141st Runner up-Ankit Chowdhury, B.Pharm 1styear, 2014

2nd Runner up-Smaranjeet Banik, B.Pharm 3rdyear, 2014Congratulation to the winner of Chess Tournament (Girls)-

Rituparna Das, B.Pharm 3rdyear, 20141st Runner up-Varsa Srivastav, B.Sc(Bioptechnology Department)

1styear, 2014

2nd Runner up- Krishnakali Basu, B.Pharm 3rdyear, 2014

The GNIPST Cricket Tournament, Carom Tournament and Chess

Tournament was held on 21st

and 22nd

October, 2014.The Cultural Programme on Bijoya Dashami and Kali Puja was

held on 20thOctober, 2014

An exhibition on Photography and Painting was held on 20thOctober, 2014


12


14/19

09-01-2015

Congratulation to the winner of Football Tournament-B.Pharm3rd year, 2014Runner up team-B.Pharm final year, 2014

Congratulation to the winner of Table Tennis Tournament-Krishnakali Basu, B.Pharm 3rd year, 20141st Runner up-Aindrila Bhowmick, B.Pharm 2nd year, 2014

2nd Runner up-Sayani Banerjee, B.Pharm 2nd year, 2014

The GNIPST Football Tournament (for male students) and TableTennis tournament (for female students) was held on 25th and

26th September, 2014.

On 5th September, 2014 the students of GNIPST have arranged a

wonderful Teachers Day Programme. On behalf of all the teachersof GNIPST I would like to thank our beloved students.

The Freshers welcome programme was held on 14thAugust, 2014.Welcome 1styear students.

We congratulate the following M.Pharm. final year students whohave made their positions in different pharmaceutical companies.

Anirban Banerjee (Emami Ltd.)

Mahender Roy (Stadmed private Ltd.)

We congratulate the following B.Pharm. final year students fortheir success.

Samadrita Mukherjee (Abbott India Ltd.)

Suman Sarkar (Tata Medical Centre-Apollo Pharmacy)

Shrewashee Mukherjee (Fresenius Kabi-Parenteral Nutrition)

Avishek Naskar (Glaxo SmithKline-Marketing)

Bappaditya Manik (USV Limited)Sarbani Das (Nutri Synapzz-Marketing)

Ankita Roy (Nutri Synapzz-Marketing)

Rahul Mitra (B M Pharmaceuticals-Production)


13


15/19

09-01-2015

The following B.Pharm. final year students have qualified, GPAT-2014. We congratulate them all.

Utsha Sinha

Satarupa BhattacharyaSandipan Sarkar

Purbali Chakraborty

Reminiscence, 2014(GNIPST Reunion) was held in Collegecampus on 2ndFebruary,2014.

1st Annual Sports of GNIPST was held on 3rd February,2014 inCollege campus ground.

An industrial tour and biodiversity tour was conducted in Sikkimfor B.Pharm and B.Sc. students under the supervision of Mr. Asis

Bala, Ms. Jeentara Begum and Ms. Moumita Chowdhury.

B.Pharm 3rd year won the GNIPST Football Champions trophy,2013. B.Pharm 3rdyear won the final match 1-0 against B.Pharm 2nd

year. Deep Chakrabortywas the only scorer of the final.

STUDENTS SECTION

WHO CAN ANSWER FIRST????

Which day is celebrated in India

as National Mathematics Day and

Why?

Answer of Previous Issues QuestionsA) DDT


14


16/19

09-01-2015

Identify the person

Answer of Previous Issues Image

Michael Chopra

Send your thoughts/

Quiz/Puzzles/games/write-ups or any other

contributions for Students Section answ ers

of this Section [email protected]

EDITORS NOTE

It is a great pleasure for me to publish the 2nd

issue of 41th

Volume

of GNIPST BULLETIN. All the followers of GNIPST BULLETIN

are able to avail the bulletin through facebook account GNIPSTbulletin I am very much thankful to all the GNIPST members and

readers who are giving their valuable comments, encouragements

and supports. I am also thankful to Dr. Abhijit Sengupta, Director

of GNIPST for his valuable advice and encouragement. Special

thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar

and Mr. Soumya Bhattacharya for their kind co-operation and

technical supports. Thank you Mr. Soumya Bhattacharyafor thequestionnaires of the student section. An important part of the

improvement of the bulletin is the contribution of the readers. You

are invited to send in your write ups, notes, critiques or any kind of

contribution for the forthcoming special and regular issue.


15
mailto:[email protected]:[email protected]:[email protected]


17/19

09-01-2015

ARCHIVE

GNIPST organized a garment distribution programme on 28thSeptember, 2013 at Dakshineswar Kali Temple and Adyapith,

Kolkata. On this remarkable event about hundred people havereceived garments. More than hundred students and most of the

faculties participated on that day with lot of enthusiasm.

GNIPST celebrated World Heart Day (29th September) andPharmacists Day (25thSeptember)on 25thand 26thSeptember,

2013 in GNIPST Auditorium. A seminar on Violence against

woman and female foeticide was held on GNIPST Auditorium on

25th September organized by JABALA Action Research

Organization. On 26thSeptember an intra-college Oral and Poster

presentation competition related to World Pharmacists day and

Heart day was held in GNIPST. Ms. Purbali Chakraborty of

B.Pharm 4th year won the first prize in Oral Presentation. The

winner of Poster presentation was the group of Ms. Utsa Sinha,

Mr. Koushik Saha and Mr. Niladri Banerjee(B.Pharm 4thyear). A

good number of students have participated in both the

competition with their valuable views.

Teachers daywas celebrated on 5thSeptember, 2013 by the

students of GNIPST in GNIPST Auditorium.

Azalea exo tic flow er ) , the fresher welcome programme for

newcomers of GNIPST in the session 2013-14 was held on 8th

August in GNIPST Auditorium.

One day seminar cum teachers development programme forschool teachers on the theme of Recent Trends of Life Sciences

in Higher Education organized by GNIPST held on 29th June,

2013 at GNIPST auditorium. The programme was inaugurated by

Prof . Asit Guha, Director of JIS Group, Mr. U.S. Mukherjee, Dy

Director of JIS Group and Dr. Abhijit Sengupta, Director cum


16


18/19

09-01-2015

Principal of GNIPST with lamp lighting. The programme started

with an opening song performed by the B.Pharm students of this

institute. The seminar consists of a series of lectures, video

presentations and poster session. On the pre lunch session 4

lectures were given by Dr. Lopamudra Dutta, Mr. Debabrata

Ghosh Dastidar, Ms. Swati Nandy and Ms. Tamalika Chakraborty

respectively. On their presentation the speakers enlighten the

recent development of Pharmacy, Genetics and Microbiology and

their correlation with Life Sciences. On the post lunch session, Ms.

Saini Setua and Ms. Sanchari Bhattacharjee explained the recent

development and career opportunities in Biotechnology and

Hospital Management. The programme was concluded withvaledictory session and certificate distribution.

About 50 Higher secondary school teachers from different

schools of Kolkata and North& South 24 Parganas district of West

Bengal participated in this programme. A good interactive session

between participants and speakers was observed in the seminar.

The seminar was a great success with the effort of faculties, staffs

and students of our Institute. It was a unique discussion platformfor school teachers and professional of the emerging and newer

branches of Life Science.

The general body meeting of APTI, Bengal Branch has been

conducted at GNIPST on 15thJune, 2012. The program started with

a nice presentation by Dr. Pulok Kr. Mukherjee, School of Natural

Products, JU on the skill to write a good manuscript for

publication in impact journals. It was followed by nearly two hourlong discussion among more than thirty participants on different

aspects of pharmacy education. Five nonmember participants

applied for membership on that very day.


17


19/19

09-01-2015

GNIPST is now approved by AICTE and affiliated to WBUT for

conducting the two years post graduate course (M.Pharm)

in P H A R M A C O L O G Y .The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to120.

AICTE has sanctioned a release of grant under Research

Promotion Scheme (RPS) during the financial year 2012-13to

GNIPST as per the details below:

a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical

Science & Technology.

b.Principal Investigator:Dr. LopamudraDutta.

c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d.Approved duration: 3 years

e. Title of the project: Screening and identification of potential

medicinal plant of Purulia & Bankura districts of West Bengal

with respect to diseases such as diabetes, rheumatism, Jaundice,

hypertension and developing biotechnological tools for enhancing

bioactive molecules in these plants.


Documents

GNIPST Bulletin 41.2